Ataxia Telangiectasia News and Research

RSS
Ataxia-telangiectasia (A-T) is a primary immunodeficiency disease which affects a number of different organs in the body. An immunodeficiency disease is one that causes the immune system to break down, making the body susceptible to diseases. It is a rare, recessive genetic disorder of childhood that occurs in between 1 out of 40,000 and 1 out of 100,000 persons worldwide. The ailment is progressive. Patients with A-T are frequently wheelchair-bound by their teens, and the disease is generally fatal to patients by the time they reach their twenties.
NAC improves effectiveness of adoptive cell therapy for treating melanoma

NAC improves effectiveness of adoptive cell therapy for treating melanoma

Substance NAD+ can extend life and postpone onset of aging processes

Substance NAD+ can extend life and postpone onset of aging processes

Intestinal bacteria can be used to reduce cancer risk, reveals UCLA study

Intestinal bacteria can be used to reduce cancer risk, reveals UCLA study

Study identifies gene linked to rare, complex diseases

Study identifies gene linked to rare, complex diseases

Neurocutaneous disorders affect skin, nervous system

Neurocutaneous disorders affect skin, nervous system

Sanford Research scientists develop animal model to study neurodegenerative disease

Sanford Research scientists develop animal model to study neurodegenerative disease

Research provides insights into the ability of FL118 to overcome treatment resistance

Research provides insights into the ability of FL118 to overcome treatment resistance

Researchers show importance of DNA damage in fine tuning of innate immune system

Researchers show importance of DNA damage in fine tuning of innate immune system

TAU's Yosef Shiloh receives Olav Thon Foundation's first international research award

TAU's Yosef Shiloh receives Olav Thon Foundation's first international research award

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

FL118 agent shows efficacy as personalized, targeted therapy for certain cancer tumors

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Study of rare childhood neurodegenerative diseases identifies new source of DNA damage

Scientists discover why cerebellar granule cell neurons in A-T patients fail to repair DNA damage

Scientists discover why cerebellar granule cell neurons in A-T patients fail to repair DNA damage

Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck and CNIO sign agreement to collaborate in area of cancer drug development

Merck signs license agreement with CNIO for cancer drug development

Merck signs license agreement with CNIO for cancer drug development

Specific types of intestinal bacteria are major contributors to lymphoma

Specific types of intestinal bacteria are major contributors to lymphoma

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Novel drug may increase the effectiveness of radiation therapy for brain cancer

Disease-in-a-dish models show promise for treating ataxia telangiectasia

Disease-in-a-dish models show promise for treating ataxia telangiectasia

Research discovery may lead to effective new treatments for neurodegenerative disease

Research discovery may lead to effective new treatments for neurodegenerative disease

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

DLKI-DIO3 miRNA cluster suppresses spread of cancer from its primary site

Scientists discover new signalling pathway that controls both obesity and atherosclerosis

Scientists discover new signalling pathway that controls both obesity and atherosclerosis